NYSE:IBM - IBM Stock Price, Forecast & News

IBM trades on the New York Stock Exchange (NYSE) under the ticker symbol "IBM."

IBM declared a quarterly dividend on Wednesday, January 29th. Investors of record on Monday, February 10th will be paid a dividend of $1.62 per share on Tuesday, March 10th. This represents a $6.48 dividend on an annualized basis and a yield of 4.29%. The ex-dividend date of this dividend is Friday, February 7th. View IBM's Dividend History.

IBM announced that its Board of Directors has authorized a stock buyback program on Tuesday, October 30th 2018, which authorizes the company to repurchase $4,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 3.5% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company's board of directors believes its stock is undervalued.

IBM (NYSE:IBM) posted its quarterly earnings data on Tuesday, January, 21st. The technology company reported $4.71 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $4.69 by $0.02. The technology company had revenue of $21.78 billion for the quarter, compared to analysts' expectations of $21.62 billion. IBM had a return on equity of 65.38% and a net margin of 12.23%. The business's quarterly revenue was up .1% compared to the same quarter last year. During the same quarter last year, the firm earned $4.87 earnings per share. View IBM's Earnings History.

IBM is scheduled to release their next quarterly earnings announcement on Tuesday, April 21st 2020. View Earnings Estimates for IBM.

IBM issued an update on its FY20 earnings guidance on Tuesday, January, 21st. The company provided earnings per share (EPS) guidance of at least $13.35 for the period, compared to the Thomson Reuters consensus estimate of $13.29.

17 analysts have issued twelve-month target prices for IBM's shares. Their forecasts range from $135.00 to $173.00. On average, they expect IBM's share price to reach $154.50 in the next year. This suggests a possible upside of 2.2% from the stock's current price. View Analyst Price Targets for IBM.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IBM in the last year. There are currently 12 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for IBM.

News headlines about IBM stock have trended somewhat positive recently, InfoTrie Sentiment reports. The research firm identifies negative and positive media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. IBM earned a news impact score of 1.3 on InfoTrie's scale. They also gave news coverage about the technology company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for IBM.

Some companies that are related to IBM include Accenture (ACN), Cognizant Technology Solutions (CTSH), Leidos (LDOS), Gartner (IT), EPAM Systems (EPAM), Booz Allen Hamilton (BAH), Amdocs (DOX), Caci International (CACI), Mantech International (MANT), Teradata (TDC), Virtusa (VRTU), Unisys (UIS), Forrester Research (FORR), The Hackett Group (HCKT) and Servicesource International (SREV).

Based on aggregate information from My MarketBeat watchlists, some companies that other IBM investors own include AT&T (T), Intel (INTC), Cisco Systems (CSCO), Exxon Mobil (XOM), NVIDIA (NVDA), General Electric (GE), Walt Disney (DIS), Verizon Communications (VZ), Johnson & Johnson (JNJ) and Alibaba Group (BABA).

IBM's stock is owned by many different of retail and institutional investors. Top institutional investors include UBS Asset Management Americas Inc. (0.45%), Amundi Pioneer Asset Management Inc. (0.30%), Fort Washington Investment Advisors Inc. OH (0.08%), OLD Republic International Corp (0.07%), Comerica Bank (0.03%) and Nisa Investment Advisors LLC (0.03%). Company insiders that own IBM stock include Bene Robert F Del, David N Farr, Diane J Gherson, Erich Clementi, Kenneth M Keverian, Sidney Taurel and Virginia M Rometty. View Institutional Ownership Trends for IBM.

IBM stock was sold by a variety of institutional investors in the last quarter, including AJO LP, MUFG Securities EMEA plc, Mairs & Power INC, Albion Financial Group UT, Intercontinental Wealth Advisors LLC, Huntington National Bank, M. Kraus & Co and Nisa Investment Advisors LLC. Company insiders that have sold IBM company stock in the last year include Bene Robert F Del, Erich Clementi and Kenneth M Keverian. View Insider Buying and Selling for IBM.

IBM stock was bought by a variety of institutional investors in the last quarter, including Amundi Pioneer Asset Management Inc., OLD Republic International Corp, Fort Washington Investment Advisors Inc. OH, Exane Derivatives, UBS Asset Management Americas Inc., John G Ullman & Associates Inc., DAVENPORT & Co LLC and Baxter Bros Inc.. Company insiders that have bought IBM stock in the last two years include David N Farr, Sidney Taurel and Virginia M Rometty. View Insider Buying and Selling for IBM.

Shares of IBM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of IBM stock can currently be purchased for approximately $151.22.

IBM has a market capitalization of $133.93 billion and generates $77.15 billion in revenue each year. The technology company earns $9.43 billion in net income (profit) each year or $12.81 on an earnings per share basis. IBM employs 381,100 workers across the globe.View Additional Information About IBM.

The official website for IBM is http://www.ibm.com/.

IBM's mailing address is 1 NEW ORCHARD ROAD, ARMONK NY, 10504. The technology company can be reached via phone at 914-499-1900 or via email at [email protected]